Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
startups
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
axial spondyloarthritis
bausch health
biogen
biotech & health
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
eddingpharm
eli lilly
elizabeth holmes
fremanezumab
fulcrum therapeutics
What
bio
2
×
new
2
×
news
2
×
accelerating
alleviate
approval
area
biogen’s
biopharmaceutical
bounds
cells
clearly
companies
conditions
controversial
controversy
convo
cost
drug
earlier
failures
futuristic
generating
grown
hailed
harvesting
human
industrial
investment
involves
leaps
levels
littered
major
medical
medicine
method
mini
nash
organs
Language
unset
Current search:
bio
×
new
×
news
×
@techcrunch.com
2 months ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
